Search clinical trials for: Icodextrin, xylitol and carnitine solution for peritoneal dialysis

Total 60 results

Iperboreal Pharma Srl

Not yet recruiting

Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine

End Stage Renal Disease (ESRD)
RenJi Hospital

Not yet recruiting

The Difference Between Daily and Alternative Day Use of Icodextrin

Peritoneal Dialysis Solution Adverse Reaction
First Affiliated Hospital, Sun Yat-Sen University
Baxter Healthcare Corporation

Recruiting

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

Peritoneal Dialysis

China
Baxter Healthcare Corporation

Withdrawn

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Peritoneal Dialysis | Hypertriglyceridemia

United States
Iperboreal Pharma Srl

Not yet recruiting

Peritoneal Ultrafiltration in Cardio Renal Syndrome. (PURE)

Congestive Heart Failure

Italy
Lawson Health Research Institute
Baxter Healthcare Corporation

Completed

Use of a Bimodal Solution for Peritoneal Dialysis

End Stage Renal Disease

Canada
Chinese University of Hong Kong

Completed

Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis

Peritonitis

Hong Kong
Fresenius Medical Care Deutschland GmbH

Completed

Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD (PDOne)

Chronic Kidney Failure

United Kingdom, Denmark, Sweden, France, Germany
Yonsei University

Completed

The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease

Chronic Kidney Disease | Refractory Heart Failure

Korea, Republic of
Ottawa Hospital Research Institute
Heart and Stroke Foundation of Ontario

Completed

Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis (SAPD)

End-stage Renal Disease (ESRD) | Kidney Disease

Canada
Yonsei University

Completed

Effect of Icodextrin Solution on Preservation of Residual Renal Function in Patients on Peritoneal Dialysis

End Stage Renal Disease

Korea, Republic of
Lawson Health Research Institute

Completed

Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients

Chronic Kidney Failure

Canada
Dong-A University
Baxter Healthcare Corporation

Completed

Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients

End Stage Renal Disease

Korea, Republic of
Baxter Healthcare Corporation

Completed

A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis

End Stage Renal Disease

Sweden
Martini Hospital Groningen
Baxter Healthcare Corporation; Roche BV Netherlands

Terminated

Peritoneal Dialysis in Congestive Heart Failure (PDinCHF)

Congestive Heart Failure

Netherlands
The People's Hospital of Gaozhou

Recruiting

Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution

Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution in Improving Nutritional Status of Maintenance Peritoneal Dialysis Patients

China
Baxter Healthcare Corporation

Completed

A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis

End Stage Renal Disease

Canada
Pontifícia Universidade Católica do Paraná
Baxter Healthcare Corporation

Completed

Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients (STARCH)

Disorders Associated With Peritoneal Dialysis

Brazil
Instituto Mexicano del Seguro Social
Sequana Medical N.V.

Recruiting

Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution

Chronic Kidney Diseases

Mexico
Vanderbilt University

Completed

The Measurement of Insulin Resistance in Peritoneal Dialysis Patients

End Stage Renal Disease

United States
Iperboreal Pharma Srl

Terminated

Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

End Stage Renal Disease

Italy
University Hospital Tuebingen

Completed

Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis

Adhesions

Germany
RenJi Hospital

Not yet recruiting

Incremental PD With Single Icodextrin Exchange

Survival | Health-related Quality of Life | Peritoneal Dialysis Complication | Residual Kidney Function
Uppsala University

Unknown

Does Icodextrin Reduce the Risk of Small Bowel Obstruction?

Surgical Adhesions

Sweden
Pr Eric Goffin

Completed

Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD. (DIDo)

Renal Insufficiency

Belgium
Baxter Healthcare Corporation

Terminated

Heart Failure and Peritoneal Ultrafiltration

Congestive Heart Failure

United States, Belgium, Canada, Australia
Baxter Healthcare Corporation

Completed

Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients (EDEN)

Diabetes | End Stage Renal Disease (ESRD) | CAPD

Colombia
University of North Carolina, Chapel Hill
Fresenius Medical Care North America

Withdrawn

The Impact of Delflex on Mesothelial Cell Viability and Peritoneal Transport (Delflex)

End Stage Renal Disease
Chinese PLA General Hospital

Completed

Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate (SEED)

Kidney Failure,Chronic

China
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD | CAPD | APD

Taiwan, Korea, Republic of, Singapore, Hong Kong, Russian Federation
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD

Australia, Canada, New Zealand
University of Aarhus

Terminated

Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis

Peritoneal Dialysis

Denmark
University of Nottingham
British Heart Foundation

Terminated

PD-HF: A Trial of Peritoneal Dialysis in Patients With Severe Heart Failure and Chronic Kidney Disease (PD-HF)

Heart Failure | Chronic Kidney Disease

United Kingdom
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange

Peritoneal Dialysis | Chronic Kidney Disease
Sun Yat-sen University

Unknown

A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate

Disorders Associated With Peritoneal Dialysis

China
University Hospital, Ghent

Completed

Peritoneal Dialysis Versus Haemodialysis

Hemodialysis

Belgium
Lund University
Baxter Healthcare Corporation; Universidad de Córdoba

Completed

Optimized vs. Standard Automated Peritoneal Dialysis Regimens Study (OptiStAR)

End Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic Dialysis

Argentina
University of Arkansas

Terminated

Direct Peritoneal Resuscitation in Gastroschisis

Gastroschisis

United States
Istanbul University

Completed

Outcome and Risk Factors For Mortality in Peritoneal Dialysis Patients: 20 Years Experience in a Single Turkish Center

Therapeutic Procedural Complication
Heidelberg University
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Great Ormond Street... and other collaborators

Completed

Proof of Concept of Adapted PD in Children (PC-AAPD) (PC-AAPD)

Primary Study Outcome: Sodium Clearance in Dialysis | Solute Removal | Ultrafiltration

Germany
Azienda Ospedaliero-Universitaria di Modena

Completed

Dialysate Temperature in Peritoneal Dialysis (TPD)

Peritoneal Dialysis Complication

Italy
Centre Hospitalier Universitaire de Besancon

Terminated

Transfer and Ultrafiltration In Peritoneal Dialysis (TULIPE)

End-stage Renal Disease

France
Triomed AB

Completed

A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.

Peritoneal Dialysis

Sweden
Davita Clinical Research
Baxter Healthcare Corporation

Terminated

Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis

Functionally Anuric | Hemodialysis/Peritoneal Dialysis
Assuta Ashdod Hospital

Recruiting

Biomarker Panel in Ovarian Torsion

Ovary Torsion | Adnexal Torsion

Israel
Universidad Miguel Hernandez de Elche

Completed

Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Colorectal Cancer Infection in Elective Surgery (lavage)

Surgical Site Infection
Assiut University

Unknown

Galectin-3 in Patients With Endometriosis

Endometriosis

Egypt
University Hospital, Clermont-Ferrand
Laboratoire HEMOTECH

Withdrawn

Catheter Dysfunction Rate in Patients Undergoing Kidney Replacement Therapy. Evaluation of the Safety and Efficacy of Anti-reflux Valves Without Heparin Lock Solution (DUKE)

Chronic Renal Failure | Haemodialysis, Haemodiafiltration, Haemofiltration | Kidney Replacement Therapy | Catheter Infection, Catheter Dysfunction, Catheter Related Bloodstream Infections

France
Szeged University

Unknown

Continuous Ambulatory Peritoneal Dialysis With Telemedicine

Peritoneal Dialysis, Continuous Ambulatory
Maastricht University Medical Center

Terminated

Carnitine Infusion and Insulin Resistance

Glucose Intolerance

Netherlands

Search clinical trials for: Icodextrin, xylitol and carnitine solution for peritoneal dialysis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations